Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IQ Capital is an early-stage venture capital firm based in Cambridge and London, UK. It specializes in deep tech investments across AI, robotics, quantum computing, synthetic biology, and healthtech. The firm manages over $1 billion in assets and has invested in more than 100 startups since its founding in 2006–2007. Its portfolio includes companies acquired by Oracle, Facebook/Meta, Google, Apple and others. It targets seed to Series A rounds with initial checks from $700K–$14M and can follow on up to $40M per company. While it invests heavily across deep tech—including life sciences—it does not develop drugs or own therapeutic pipelines itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IQ Capital.